Experts urge faster lung cancer screening rollout in Scotland

Lung cancer remains Scotland’s biggest cancer killer, with 3,651 deaths in 2024, accounting for more than a fifth (22.3 per cent) of all cancer deaths <i>(Image: National Cancer Institute)</i>
Lung cancer remains Scotland’s biggest cancer killer, with 3,651 deaths in 2024, accounting for more than a fifth (22.3 per cent) of all cancer deaths (Image: National Cancer Institute)
This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The Herald.

Patients can't wait another decade for lung cancer screenings in Scotland say experts.

The call to action from the UK Lung Cancer Coalition (UKLCC) was made during its first Scottish regional meeting, held in Stirling on November 10.

Lung cancer remains the leading cause of cancer death in Scotland, responsible for 3,651 deaths in 2024, and accounting for more than one in five cancer fatalities.

Dr John Maclay, consultant chest physician at Glasgow Royal Infirmary and Scottish lung cancer management pathway lead, said: "Lung cancer screening saves lives.

"Scotland risks falling further behind in terms of early detection of the disease unless efforts to roll out the screening programme are accelerated."

Currently, around 46 per cent of lung cancer cases in Scotland are diagnosed at stage four, when curative treatment is rarely possible.

Scotland ranks 27th out of 29 European countries for five-year lung cancer survival.

Despite the urgent need, Scottish ministers have indicated that a full rollout of a targeted screening programme for people aged 55 to 74 with a history of smoking may not begin until 2027 and could take up to 10 years to implement.

Dr Maclay said: "The benefits are clear to see across the border.

"While research and planning for screening has been progressing for some time in Scotland, patients are understandably concerned about delays in introducing a programme that could help diagnose lung cancer earlier."

Targeted lung cancer screening is already expanding in other parts of the UK.

In England, more than two million people have attended screening appointments, with nearly 13,000 cancers detected, three-quarters of them at an early stage.

Wales is also well advanced in its planning for a national lung cancer screening programme.

Evidence supporting targeted screening is strong.

The Scottish LUNGSCOT trial showed that such programmes can be effectively delivered across the country, including in rural and deprived areas, and can be cost-effective.

In 2022, the UK National Screening Committee (UKNSC) recommended that all four UK nations move towards implementation of targeted lung cancer screening, with inclusion of smoking cessation.

Dr David Gilligan, chair of the UKLCC and consultant oncologist at Addenbrookes Hospital, Cambridge, said: "Today's meeting brings together clinical leaders from across Scotland who are committed to turning evidence into action and ensuring that screening becomes a reality as quickly as possible.

"The UKLCC supports the Scottish Government's willingness to introduce screening, but patients can’t wait a decade for the full benefits to be realised."

Get involved
with the news

Send your news & photos